AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

AMICUS THERAPEUTICS, INC. Director's Dealing 2018

Sep 11, 2018

31523_dirs_2018-09-11_bba33345-a7ce-46e3-9078-4eecc9605fc2.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-09-07

Reporting Person: Bleil Lynn Dorsey (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Footnotes

F1: No securities beneficially owned.